Skip to main content
Skip to navigation
Research Exchange
Living Lab
Discovery Lab
Donate
Oligoclonal B cell expansion and passenger fusion genes predict response to Nivolumab in recurrent ovarian cancer: phase II Kyoto trial
Ryusuke Murakami & Junzo Hamanishi
· 2026-01-27
Links
DOI
PubMed
Journal
Cancer Immunology, Immunotherapy
Institutions
Kyoto University
Authors
Ryusuke Murakami
,
Junzo Hamanishi
Funding
Japan Agency for Medical Research and Development (AMED) grant Grant 15 cm0106133h0002
Japanese Society for the Promotion of Science Grant grant 17K19591 and 24K12601